2 The immunogenetics of the seronegative spondyloarthropathies

https://doi.org/10.1016/S0950-3579(98)80038-1Get rights and content

In none of the rheumatic diseases has the genetic contribution to pathogenesis been so well characterized as in the seronegative spondyloarthropathies. Most important has been the elucidation of the structure and effect on disease expression of HLA-B27, where 11 subtypes have been distinguished to date. These vary in frequency in different ethnic groups and seem to show differential disease associations. The high frequency of this gene in patients with the seronegative spondyloarthropathies, especially ankylosing spondylitis (AS) and Reiter's syndrome (RS)/reactive arthritis (ReA), has emerged as probably the best example of a disease association with a hereditary marker. Other HLA genes, in addition to HLA-B27, have been implicated in psoriasis and psoriatic arthritis. These include those from the HLA-C locus and from HLA-DR. In addition, recent family studies have implicated other genes outside the MHC that further enhance the susceptibility to AS.

References (134)

  • GeraghtyDE

    Structure of the HLA class I region and expresson of its resident genes

    Current Opinion in Immunology

    (1993)
  • Gonzalez-RocesS et al.

    Molecular analysis of HLA-B27 haplotypes in Caucasoids: frequencies of B27-CW in Jewish and Spanish populations

    Human Immunology

    (1994)
  • GranforsK et al.

    Salmonella lipopoly-saccharide in synovial cells from patients with reactive arthritis

    Lancet

    (1990)
  • HammerRE et al.

    Spontaneous inflammatory disease in transgenic rats expressing HLA-B27-associated human disorders

    Cell

    (1990)
  • HermannE et al.

    HLA-B27 restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis

    Lancet

    (1993)
  • HillASV et al.

    HLA class I typing by PCR: HLA-B27 and an African B27 subtype

    Lancet

    (1991)
  • HillAVS et al.

    HLA class I typing by PCR: HLA-B27 and an African B27 subtype

    Lancet

    (1991)
  • HohlerT et al.

    TAP-polymorphisms in juvenile onset psoriasis and psoriatic arthritis

    Human Immunology

    (1996)
  • HohlerT et al.

    A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis

    Journal of Investigative Dermatology

    (1997)
  • KammerGM et al.

    Psoriatic arthritis: a clinical, immunological and HLA study of 100 patients

    Seminars in Arthritis and Rheumatism

    (1979)
  • MaddenDR et al.

    The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC

    Cell

    (1992)
  • AlexeevaL et al.

    Prevalence of Spondyloarthropathies and HLA-B27 in the native population of Chukotka, Russia

    Journal of Rheumatology

    (1994)
  • D'amatoM et al.

    Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis

    European Journal of Immunology

    (1995)
  • ArcherJR et al.

    Effect of a free sulphydryl group on expression of HLA-B27 specificity

    Scandinavian Journal of Rheumatology

    (1990)
  • ArmstrongRD et al.

    Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis

    Annals of the Rheumatic Diseases

    (1983)
  • ArnettFC et al.

    Homozygosity for HLA-B27. Impact on rheumatic disease expression in two families

    Arthritis and Rheumatism

    (1977)
  • ArnettFC et al.

    Cross-reactive HLA antigens in B27-negative Reiter's syndrome and sacroiliitis

    Johns Hopkins Medical Journal

    (1977)
  • BaechJ et al.

    Frequency of HLA-B27 subtypes in a Danish population and in Danish patients with ankylosing spondylitis

    Tissue Antigens

    (1997)
  • BarronKS et al.

    Susceptibility to Reiter's syndrome is associated with alleles of TAP genes

    Arthritis and Rheumatism

    (1995)
  • BeaulieuAD et al.

    Psoriatic arthritis: risk factors for patients with psoriasis—a study based on histocompatibility antigen frequencies

    Journal of Rheumatology

    (1983)
  • BjorkmanPJ et al.

    Structure of the human class I histocompatibility antigen, HLA-A2

    Nature

    (1987)
  • BrautbarC et al.

    HLA-B27 and ankylosing spondylitis in the Israeli population

    Journal of Rheumatology

    (1977)
  • Breur-VriesendorpBS et al.

    Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules

    Annals of the Rheumatic Diseases

    (1987)
  • BrownM et al.

    Predisposing factors to spondyloarthropathies

    Current Opinion in Rheumatology

    (1997)
  • BrownMA et al.

    Susceptibility to ankylosing spondylitis in twins-the role of genes, HLA, and the environment

    Arthritis and Rheumatism

    (1997)
  • BrownMA et al.

    A genome-wide screen for susceptibility loci in ankylosing spondylitis

    Arthritis and Rheumatism

    (1998)
  • Burgos-VargasR et al.

    The early clinical recognition of juvenile-onset ankylosing spondylitis and its differentiation from juvenile rheumatoid arthritis

    Arthritis and Rheumatism

    (1995)
  • BuxtonSE et al.

    Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B (‘45’) pocket of HLA-B27

    Journal of Experimental Medicine

    (1992)
  • CalinA et al.

    An ‘experimental’ epidemic of Reiter's syndrome revisited: follow-up evidence on genetic and environmental factors

    Annals of Internal Medicine

    (1976)
  • CedozJP et al.

    The B7 cross reactive group and spondylo-arthropathies: an epidemiological approach

    Journal of Rheumatology

    (1995)
  • ChalmersIM

    Ankylosing spondylitis in African blacks

    Arthritis and Rheumatism

    (1980)
  • ChanSH et al.

    HLA-B27 and Chinese ankylosing spondylitis

    Singapore Medical Journal

    (1980)
  • ChooSY et al.

    A novel HLA-B27 allele maps B27 allospecificity to the region around position 70 in the alpha 1 domain

    Journal of Immunology

    (1991)
  • ChooSY et al.

    Six variants of HLA-B27 identified by isoelectric focussing

    Immunogenetics

    (1986)
  • DavatchiF et al.

    Histocompatibility antigen (HLA) in rheumatic diseases in Iran

    Journal of Rheumatology

    (1977)
  • DeceulaerK et al.

    Sausage-like toes (dactylitis) and HLA B27

    Journal of Rheumatology

    (1997)
  • Dekker-SaeysBJ et al.

    Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease

    Annals of the Rheumatic Diseases

    (1978)
  • O'DonnellBF et al.

    HLA typing in Irish psoriatics

    Irish Medical Journal

    (1993)
  • DuchmannR et al.

    HLA-B27-restricted cytotoxic T lymphocyte responses to arthritogenic enterobacteria or self-antigens are dominated by closely related TCRBV gene segments: a study in patients with reactive arthritis

    Scandinavian Journal of Immunology

    (1996)
  • EdmondsJ et al.

    HLA-B27-negative ankylosing spondylitis

  • Cited by (17)

    • The role of the gut microbiome in eye diseases

      2023, Progress in Retinal and Eye Research
      Citation Excerpt :

      It has been known for many centuries as a triad of arthritis, nongonococcal urethritis, conjunctivitis and/or nongranulomatous anterior uveitis (Aceves-Avila et al., 1998) and is known to be triggered by a bacterial infection, possibly shedding of microbes from dysbiosis in the gut, particularly of the genitourinary (Chlamydia trachomatis) or gastrointestinal tract (Shigella, Salmonella, and Campylobacter) (Wu and Schwartz, 2008). Human leukocyte antigen B27 is strongly associated with Reiter's syndrome with about 60%–80% of patients being positive, compared with 10% in the general population (Al-Khonizy and Reveille, 1998; Callen and Mahl, 1992). The exact pathophysiology of this disease is unknown.

    • Multisystem diseases affecting the skin and eye

      2016, Clinics in Dermatology
      Citation Excerpt :

      In addition, because not all patients who are exposed to these infections develop reactive arthritis, individuals are felt to be predisposed to getting reactive arthritis. HLA-B27 also is associated with reactive arthritis, with 60-80% of patients being positive and up to 20% of HLA-B27–positive patients developing reactive arthritis after Shigella or Salmonella outbreaks.29,30 There can be a wide range of clinical presentations of reactive arthritis in regard to timing after exposure to the infectious organism, disease severity, and varying multisystemic manifestations.

    • Reiter's syndrome: The classic triad and more

      2008, Journal of the American Academy of Dermatology
      Citation Excerpt :

      HLA-B27 is strongly associated with Reiter's syndrome, with about 60% to 80% of patients being positive, compared with 10% in the general population.16,38-40 Up to 20% of patients who are HLA-B27 positive develop reactive arthritis after Shigella or Salmonella outbreaks.41 Some case reports have also noted a possible association of reactive arthritis with HLA-B51.42,43

    • Genetic Markers of Joint Disease

      2006, Dynamics of Bone and Cartilage Metabolism: Principles and Clinical Applications
    • Genetic Markers of Joint Disease

      2006, Dynamics of Bone and Cartilage Metabolism
    View all citing articles on Scopus
    View full text